WONG RODERICK

Insider Buys Quantity –
24
2022-10-06PurchaseRocket Pharmaceuticals, Inc.
RCKT
director
1.36M
1.6286%
$14.75$20M+5.69%
2022-09-07SaleMilestone Pharmaceuticals Inc.
MIST
1.56M
3.6651%
$8.71$13.56M-56.03%
2022-09-07PurchaseMilestone Pharmaceuticals Inc.
MIST
1.56M
3.6651%
$8.71$13.56M-56.03%
2019-12-11PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
63,000
0.152%
$10.92$688,048+120.76%
2019-12-10PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
51,942
0.1248%
$10.38$539,033+131.16%
2019-12-06PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
900,000
2.2159%
$10.24$9.22M+137.38%
2019-12-05PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
40,000
0.0977%
$10.15$406,000+137.31%
2019-12-04PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
40,000
0.0974%
$10.15$406,000+136.32%
2019-12-03PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
40,000
0.0982%
$10.21$408,400+133.43%
2019-12-02PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
40,000
0.0971%
$10.30$412,200+126.86%
2019-11-29PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
53,836
0.1312%
$10.45$562,586+123.83%
2019-11-27PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
8,000
0.0195%
$10.48$83,807+123.07%
2019-11-26PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
8,000
0.0195%
$10.48$83,864+121.33%
2019-11-25PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
8,000
0.0195%
$10.49$83,904+119.71%
2019-11-22PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
4,000
0.0097%
$10.54$42,160+115.36%
2019-11-21PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
30,388
0.0728%
$10.42$316,597+114.29%
2019-11-20PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
59,610
0.1458%
$10.39$619,163+119.42%
2019-11-19PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
59,610
0.146%
$10.25$611,003+122.55%
2019-11-18PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
59,610
0.1463%
$10.25$611,003+122.1%
2019-11-15PurchaseImmunovant, Inc.
IMVT
Chief Executive Officer
26,000
0.0639%
$10.29$267,600+107.65%